EFFECT OF SACUBITRIL/VALSARTAN ON SERUM LIPIDS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF

被引：0
|
作者：
Selvaraj, Senthil
Claggett, Brian
Packer, Milton
Zannad, Faiez
Ananda, Inderjit
Pieske, Burkert
Shi, Victor
Lefkowitz, Martin
McMurray, John
Solomon, Scott
机构：
[1] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：556 / 556
页数：1
相关论文
共 50 条
  • [21] Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
    Solomon, Scott D.
    Rizkala, Adel R.
    Lefkowitz, Martin P.
    Shi, Victor C.
    Gong, JianJian
    Anavekar, Nagesh
    Anker, Stefan D.
    Arango, Juan L.
    Arenas, Jose L.
    Atar, Dan
    Ben-Gal, Turia
    Boytsov, Sergey A.
    Chen, Chen-Huan
    Chopra, Vijay K.
    Cleland, John
    Comin-Colet, Josep
    Duengen, Hans-Dirk
    Echeverria Correa, Luis E.
    Filippatos, Gerasimos
    Flammer, Andreas J.
    Galinier, Michel
    Godoy, Armando
    Goncalvesova, Eva
    Janssens, Stefan
    Katova, Tzvetana
    Kober, Lars
    Lelonek, Malgorzata
    Linssen, Gerard
    Lund, Lars H.
    O'Meara, Eileen
    Merkely, Bela
    Milicic, Davor
    Oh, Byung-Hee
    Perrone, Sergio V.
    Ranjith, Naresh
    Saito, Yoshihiko
    Saraiva, Jose F.
    Shah, Sanjiv
    Seferovic, Petar M.
    Senni, Michele
    Sibulo, Antonio S., Jr.
    Sim, David
    Sweitzer, Nancy K.
    Taurio, Jyrki
    Vinereanu, Dragos
    Vrtovec, Bojan
    Widimsky, Jiri
    Yilmaz, Mehmet B.
    Zhou, Jingmin
    Zweiker, Robert
    CIRCULATION-HEART FAILURE, 2018, 11 (07)
  • [22] ABDOMINAL OBESITY AND OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE PARAGON-HF TRIAL
    Peikert, Alexander
    Vaduganathan, Muthiah
    Claggett, Brian
    Kulac, Ian
    Litwin, Sheldon E.
    Zile, Michael R.
    Pfeffer, Marc A.
    Desai, Akshay S.
    Jhund, Pardeep S.
    Butt, Jawad Haider
    Rouleau, Jean L.
    Lefkowitz, Martin
    McMurray, John J. V.
    Solomon, Scott D.
    Packer, Milton
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 361 - 361
  • [23] Cardiovascular-kidney-metabolic overlap in heart failure with preserved ejection fraction: Cardiac structure and function, clinical outcomes, and response to sacubitril/valsartan in PARAGON-HF
    Lassen, Mats C. H.
    Ostrominski, John W.
    Claggett, Brian L.
    Packer, Milton
    Zile, Michael
    Desai, Akshay S.
    Shah, Amil M.
    Cikes, Maja
    Merkely, Bela
    Gori, Mauro
    Wang, Xiaowen
    Hegde, Sheila M.
    Pfeffer, Marc A.
    Lefkowitz, Martin
    McMurray, John J. V.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (08) : 1762 - 1774
  • [24] PARAGON-HF - considerations for potential use of sacubitril-valsartan in real-world heart failure with mildly reduced ejection fraction
    Lund, Lars H.
    Savarese, Gianluigi
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (12) : 1012 - 1013
  • [25] Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
    Vaduganathan, Muthiah
    Mentz, Robert J.
    Claggett, Brian L.
    Miao, Zi Michael
    Kulac, Ian J.
    Ward, Jonathan H.
    Hernandez, Adrian F.
    Morrow, David A.
    Starling, Randall C.
    Velazquez, Eric J.
    Williamson, Kristin M.
    Desai, Akshay S.
    Zieroth, Shelley
    Lefkowitz, Martin
    McMurray, John J., V
    Braunwald, Eugene
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2982 - 2993
  • [26] Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF
    Inciardi, Riccardo Maria
    Mentz, R. J.
    Claggett, B.
    Ward, J. H.
    Hernandez, A. F.
    Morrow, D. A.
    Starling, R. C.
    Velazquez, E. J.
    Desay, A. S.
    Zieroth, S.
    Lefkowitz, M.
    Mcmurray, J. J. V.
    Braunwald, E.
    Solomon, S. D.
    Vaduganathan, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 67 - 67
  • [27] Response by Shen et al to Letter Regarding Article, "Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF"
    Shen, Li
    Jhund, Pardeep S.
    Mcmurray, John J. V.
    CIRCULATION, 2025, 151 (06) : e38 - e38
  • [28] Diabetes and prediabetic dysglycaemia in patients with heart failure and preserved ejection fraction: An analysis of PARAGON-HF
    Roerth, R.
    Jackson, A.
    Lam, C. S. P.
    Anand, I. S.
    Chopra, V. J.
    FCleland, J. G.
    Maggioni, A. P.
    Martinez, F. A.
    Packer, M.
    Pfeffer, M. A.
    Pieske, B.
    Yilmaz, M. B.
    Zile, M. R.
    Solomon, S. D.
    Mcmurray, J. John
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 7 - 7
  • [29] SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF
    Selvaraj, Senthil
    Claggett, Brian
    Bohm, Michael
    Anker, Stefan D.
    Vaduganathan, Muthiah
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 680 - 680
  • [30] Letter by Wu and Zhao Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF"
    Wu, Kai
    Zhao, Song
    CIRCULATION, 2020, 142 (01) : E3 - E4
12345